| Treating oxidative stress in heart failure: past, present and future A van der Pol, WH van Gilst, AA Voors, P van der Meer European Journal of Heart Failure 21 (4), 425-435, 2019 | 644 | 2019 |
| Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction J Tromp, A van der Pol, IJT Klip, RA de Boer, T Jaarsma, WH van Gilst, ... Circulation: Heart Failure 7 (3), 457-462, 2014 | 88 | 2014 |
| Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH A Van Der Pol, A Gil, HHW Silljé, J Tromp, ES Ovchinnikova, ... Science translational medicine 9 (415), eaam8574, 2017 | 56 | 2017 |
| OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection … A van der Pol, A Gil, J Tromp, HHW Sillje, DJ van Veldhuisen, AA Voors, ... Cardiovascular Research 114 (14), 1871-1882, 2018 | 52 | 2018 |
| In Vitro Methods to Model Cardiac Mechanobiology in Health and Disease I Jorba, D Mostert, LHL Hermans, A van der Pol, NA Kurniawan, ... Tissue Engineering Part C: Methods 27 (3), 139-151, 2021 | 41 | 2021 |
| Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart A van der Pol, MF Hoes, RA de Boer, P Van Der Meer Journal of Internal Medicine 288 (5), 491-506, 2020 | 33 | 2020 |
| Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure EL Vegter, ES Ovchinnikova, HHW Silljé, LMG Meems, A van der Pol, ... PLoS One 12 (5), e0177242, 2017 | 30 | 2017 |
| LC-MS analysis of key components of the glutathione cycle in tissues and body fluids from mice with myocardial infarction A Gil, A van der Pol, P van der Meer, R Bischoff Journal of pharmaceutical and biomedical analysis 160, 289-296, 2018 | 22 | 2018 |
| P. van der Meer Treating oxidative stress in heart failure: Past, present and future., 2019, 21 A Van der Pol, WH van Gilst, AA Voors DOI: https://doi. org/10.1002/ejhf 1320, 425-435, 0 | 8 | |
| A brief history in cardiac regeneration, and how the extra cellular matrix may turn the tide A Van der Pol, CVC Bouten Frontiers in Cardiovascular Medicine 8, 682342, 2021 | 7 | 2021 |
| Cardiac regeneration in left ventricular dysfunction: are we asking the right questions? A van der Pol, I Domian, P van der Meer European journal of heart failure 14 (1), 1-4, 2011 | 5 | 2011 |
| Steering cell orientation through light-based spatiotemporal modulation of the mechanical environment I Jorba, S Gussenhoven, A van der Pol, BGW Groenen, M van Zon, ... Biofabrication 16 (3), 035011, 2024 | 3 | 2024 |
| Hydrogels for Cardiac Restorative Support: Relevance of Gelation Mechanisms for Prospective Clinical Use VC Vetter, CVC Bouten, A van der Pol Current heart failure reports 20 (6), 519-529, 2023 | 3 | 2023 |
| Spatial regulation of substrate adhesion directs fibroblast morphotype and phenotype M D’Urso, I Jorba, A van der Pol, CVC Bouten, NA Kurniawan PNAS nexus 3 (8), pgae289, 2024 | 1 | 2024 |
| GelMA hydrogel dual photo-crosslinking to dynamically modulate ECM stiffness JJHM Smits, A Van Der Pol, MJ Goumans, CVC Bouten, I Jorba Frontiers in Bioengineering and Biotechnology 12, 1363525, 2024 | | 2024 |
| The effect of mechanical stretch on phospholamban mutated (PLN R14del) cardiomyocytes A van der Pol, J van der Geest, A Al-Khaqani, JPG Sluijter, CVC Bouten, ... European Society for Cardiology: Heart Failure, 2023 | | 2023 |
| Bio-engineering a Hybrid Material for Heart Regeneration: combining a Synthetic Hydrogel with Fetal Cardiac Extracellular Matrix A van der Pol, SMJ de Jong, P Everts, P van der Meer, PYW Dankers, ... Matrix Biology Europe, 2022 | | 2022 |
| The cardiac fetal gene program in heart failure: From OPLAH to 5-oxoproline and beyond A van der Pol | | 2018 |
| 5-oxoprolinase: a Novel Cardiac Mediator of the Oxidative Stress Response in the Failing Heart A van der Pol, J Tromp, MF Hoes, IJ Domian, WH van Gilst, H Silljé, ... Circulation 130 (suppl_2), A19908-A19908, 2014 | | 2014 |
| Circulating Levels of the Fibrosis Marker Syndecan-1 Predict Outcome in Heart Failure With Preserved Ejection Fraction J Tromp, A van der Pol, IJT Klip, RA de Boer, T Jaarsma, AA Voors, ... Circulation 128 (suppl_22), A14681-A14681, 2013 | | 2013 |
